Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Serplulimab”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT05584137
What this trial is testing

Evaluate the Efficacy, Safety and Tolerability of HLX26 and Serplulimab in Patients with MCRC

Who this might be right for
Colorectal Cancer Metastatic
Shanghai Henlius Biotech 2
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07403435
What this trial is testing

Short-course Radiotherapy Combined With Serplulimab and Chemotherapy as Neoadjuvant Treatment for Resectable ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 22
Large-scale testing (Phase 3)Study completedNCT05807893
What this trial is testing

Study to Evaluate the Safety and Efficacy of Serplulimab Plus Bevacizumab and Chemotherapy in NSCLC Patients With Brain Metastases

Who this might be right for
Non-small Cell Lung Cancer Stage IIBevacizumabImmunotherapy+1 more
Sun Yat-sen University 40
Testing effectiveness (Phase 2)Looking for participantsNCT06497530
What this trial is testing

Maintenance Lurbinectedin in Combination With Serplulimab for Patients With ES-SCLC

Who this might be right for
Extensive-Stage Small Cell Lung Cancer
Guangzhou Institute of Respiratory Disease 30
Testing effectiveness (Phase 2)UnknownNCT05918419
What this trial is testing

Efficacy and Safety of Neoadjuvant Chemoradiation Plus Serplulimab in Patients With Locally Advanced Adenocarcinoma of Gastroesophageal Junction

Who this might be right for
Gastroesophageal Junction Adenocarcinoma
Peking Union Medical College Hospital 35
Testing effectiveness (Phase 2)Looking for participantsNCT06727617
What this trial is testing

Serplulimab With Chemoradiotherapy for Postoperative Cervical Cancer With Risk Factors

Who this might be right for
Cervical Cancers
Tianjin Medical University Cancer Institute and Hospital 134
Not applicableNot Yet RecruitingNCT06462105
What this trial is testing

Liposomal Irinotecan Combination Regimen for First-line Treatment of Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Zhou Chengzhi 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT05957510
What this trial is testing

Safety and Efficacy Evaluation of Serplulimab Plus Chemo in SCLC Transformed From EGFR-mutated NSCLC After Treatment

Who this might be right for
Small-cell Lung Cancer
Guangdong Association of Clinical Trials 66
Testing effectiveness (Phase 2)Looking for participantsNCT06354218
What this trial is testing

Serplulimab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old Age

Who this might be right for
Esophageal Carcinoma
The First Affiliated Hospital with Nanjing Medical University 50
Not applicableUnknownNCT05883670
What this trial is testing

Real-world Study of Serplulimab in 2L and Above Treatment of Cervical Cancer

Who this might be right for
Cervical Cancer
Shandong University 118
Large-scale testing (Phase 3)Looking for participantsNCT05173272
What this trial is testing

Induction Chemotherapy Combined With Immunotherapy Followed by Concurrent Chemoradiation in Advanced Cervical Cancer

Who this might be right for
Cervical Cancer
Sichuan Cancer Hospital and Research Institute 286
Testing effectiveness (Phase 2)Looking for participantsNCT06850103
What this trial is testing

SCRT-CAPEOX-Serplulimab for MSS/pMMR Rectal Cancer With Oligometastases

Who this might be right for
Colorectal CarcinomaOligometastasespMMR+2 more
First Affiliated Hospital of Zhejiang University 51
Testing effectiveness (Phase 2)Looking for participantsNCT06433869
What this trial is testing

The Efficacy of Bevacizumab and Serplulimab Combined With Recombinant Mutant HumanTumor Necrosis Factor(rmhTNF-NC) in the Treatment of Malignant Ascites

Who this might be right for
Malignant Ascites
Sun Yat-sen University 60
Early research (Phase 1)Looking for participantsNCT06716619
What this trial is testing

A Phase I Trial of Tumor-Associated Lymph Node T-Cell Injection With Advanced Malignant Solid Tumors

Who this might be right for
Tumor Associated Lymph Node T CellAdvanced Solid TumorImmunotherapy+1 more
Guangzhou FineImmune Biotechnology Co., LTD. 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT07257575
What this trial is testing

Controlled Study of Serplulimab Combined With Chemotherapy for Locally Advanced Gastric Adenocarcinoma

Who this might be right for
Gastric Cancer Stage III
Guangdong Provincial People's Hospital 138
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07622550
What this trial is testing

A Single-arm, Multicenter Clinical Study of Fruquintinib Combined With Serplulimab and Chemotherapy as First-line Treatment for Patients With RAS/BRAF-mutated Advanced Colorectal Cance

Who this might be right for
Metastatic Colorectal Cancer (CRC)
Jiangsu Cancer Institute & Hospital 80
Large-scale testing (Phase 3)Not Yet RecruitingNCT07277842
What this trial is testing

PD-1 + FOLFOXIRI vs CAPOX as Total Neoadjuvant Therapy for pMMR Low Rectal Cancer

Who this might be right for
Locally Advanced Low Rectal AdenocarcinomapMMR (Microsatellite Stable Rectal Cancer)
Sun Yat-sen University 382
Testing effectiveness (Phase 2)UnknownNCT05443646
What this trial is testing

Consolidation Serplulimab Following Concurrent Chemoradiotherapy for LS-SCLC Patients

Who this might be right for
Limited Stage Small Cell Lung Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 55
Large-scale testing (Phase 3)Not Yet RecruitingNCT07318883
What this trial is testing

A Phase II/III Clinical Study to Evaluate HLX07 in Combination With Serplulimab and Chemotherapy Versus Placebo in Combination With Serplulimab or Pembrolizumab and Chemotherapy as First-Line Treatment in Advanced Squamous Non-Small Cell Lung Cancer

Who this might be right for
Squamous NSCLC
Shanghai Henlius Biotech 720
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07784413
What this trial is testing

A Sequential Trial of Low-Dose Radiotherapy Followed by Concurrent Immunotherapy, Systemic Chemotherapy, and Intraperitoneal Perfusion in Gastric Cancer With Peritoneal Carcinomatosis

Who this might be right for
Gastric Cancer Peritoneal Metastasis (GCPM)
Zhejiang Cancer Hospital 40
Next Page